tiprankstipranks
Keros Therapeutics, Inc. (KROS)
NASDAQ:KROS
US Market
KROS
Keros Therapeutics
RESEARCH TOOLSreports

Keros Therapeutics (KROS) Income Statement

362 Followers

Keros Therapeutics Income Statement

Last quarter (Q4 2025), Keros Therapeutics's total revenue was $385.00K, a decrease of -87.34% from the same quarter last year. In Q4, Keros Therapeutics's net income was $-23.46M. See Keros Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 244.06M$ 3.55M$ 151.00K$ 0.00$ 20.10M
Gross Profit
$ 242.55M$ 3.55M$ 151.00K$ 0.00$ 20.10M
Operating Expenses
$ 171.93M$ 214.38M$ 170.09M$ 114.79M$ 76.47M
Depreciation and Amortization
$ 1.51M$ 1.23M$ 815.00K$ 674.00K$ 378.00K
EBITDA
$ 72.13M$ -185.82M$ -152.18M$ -104.00M$ -56.35M
Operating Income
$ 70.62M$ -210.83M$ -169.94M$ -114.79M$ -56.37M
Other Income/Expenses
$ 21.27M$ 23.78M$ 16.95M$ 10.11M$ -360.00K
Pretax Income
$ 91.90M$ -187.05M$ -152.99M$ -104.68M$ -56.73M
Net Income
$ 87.01M$ -187.35M$ -152.99M$ -104.68M$ -58.74M
Per Share Metrics
Basic EPS
$ 2.34$ -5.00$ -5.20$ -4.15$ -2.52
Diluted EPS
$ 2.30$ -5.00$ -5.20$ -4.15$ -2.52
Weighted Average Shares Outstanding
 37.22M 37.44M 29.45M 25.24M 23.33M
Weighted Average Shares Outstanding (Diluted)
 37.86M 37.44M 29.45M 25.24M 23.33M
Currency in USD

Keros Therapeutics Earnings and Revenue History